Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W DeGregorio

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|June 1, 1993
Tamoxifen resistance in breast cancerV J Wiebe, C K Osborne, S A Fuqua, et al.
Clinical Pharmacokinetics|December 7, 2000
Clinical pharmacokinetics of toremifeneT L Taras, G T Wurz, G R Linares, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Uptake and metabolism of daunorubicin by human leukemia cellsM W DeGregorio, C J Carrera, J C Klock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumorsV J Wiebe, C K Osborne, W L McGuire, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Targeting chemosensitizing doses of toremifene based on protein bindingG T Wurz, V D Emshoff, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Elevated plasma tamoxifen levels in a patient with liver obstructionM W DeGregorio, V J Wiebe, A P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistanceM W DeGregorio, J M Ford, C C Benz, et al.
Breast Cancer Research and Treatment|November 20, 1998
Intrinsic reactivity of tamoxifen and toremifene metabolites with DNAU Hellmann-Blumberg, M G Cartner, G T Wurz, et al.
Breast Cancer Research and Treatment|June 14, 2000
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifeneU Hellmann-Blumberg, T L Taras, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cellsM W DeGregorio, G M Lui, B A Macher, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|June 1, 1993
Tamoxifen resistance in breast cancerV J Wiebe, C K Osborne, S A Fuqua, et al.
Clinical Pharmacokinetics|December 7, 2000
Clinical pharmacokinetics of toremifeneT L Taras, G T Wurz, G R Linares, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Uptake and metabolism of daunorubicin by human leukemia cellsM W DeGregorio, C J Carrera, J C Klock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumorsV J Wiebe, C K Osborne, W L McGuire, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Targeting chemosensitizing doses of toremifene based on protein bindingG T Wurz, V D Emshoff, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Elevated plasma tamoxifen levels in a patient with liver obstructionM W DeGregorio, V J Wiebe, A P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistanceM W DeGregorio, J M Ford, C C Benz, et al.
Breast Cancer Research and Treatment|November 20, 1998
Intrinsic reactivity of tamoxifen and toremifene metabolites with DNAU Hellmann-Blumberg, M G Cartner, G T Wurz, et al.
Breast Cancer Research and Treatment|June 14, 2000
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifeneU Hellmann-Blumberg, T L Taras, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cellsM W DeGregorio, G M Lui, B A Macher, et al.
Pageof 6